Covington Capital Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-852
| Closed | -$157K | – | 1069 |
|
|
2021
Q2 | $157K | Buy |
852
+695
| +443% | +$128K | 0.01% | 386 |
|
|
2021
Q1 | $24K | Buy |
157
+7
| +5% | +$1.07K | ﹤0.01% | 578 |
|
|
2020
Q4 | $23K | Hold |
150
| – | – | ﹤0.01% | 569 |
|
|
2020
Q3 | $17K | Hold |
150
| – | – | ﹤0.01% | 575 |
|
|
2020
Q2 | $17K | Hold |
150
| – | – | ﹤0.01% | 576 |
|
|
2020
Q1 | $13K | Sell |
150
-230
| -61% | -$19.9K | ﹤0.01% | 584 |
|
|
2019
Q4 | $41K | Sell |
380
-162
| -30% | -$17.5K | ﹤0.01% | 501 |
|
|
2019
Q3 | $53K | Hold |
542
| – | – | ﹤0.01% | 438 |
|
|
2019
Q2 | $71K | Buy |
542
+53
| +11% | +$6.94K | ﹤0.01% | 390 |
|
|
2019
Q1 | $66K | Buy |
489
+31
| +7% | +$4.18K | ﹤0.01% | 387 |
|
|
2018
Q4 | $45K | Hold |
458
| – | – | ﹤0.01% | 439 |
|
|
2018
Q3 | $64K | Hold |
458
| – | – | ﹤0.01% | 398 |
|
|
2018
Q2 | $57K | Hold |
458
| – | – | ﹤0.01% | 412 |
|
|
2018
Q1 | $51K | Hold |
458
| – | – | ﹤0.01% | 427 |
|
|
2017
Q4 | $55K | Buy |
458
+97
| +27% | +$11.6K | ﹤0.01% | 445 |
|
|
2017
Q3 | $51K | Buy |
+361
| New | +$51K | ﹤0.01% | 432 |
|